Sana Biotechnology Inc logo

Sana Biotechnology Inc

SANA
Healthcare|Biotechnology|USA
$3.85
-0.08 (-2.04%)

Upcoming Data Readouts (7)

Jul 2026
Est. completion
NAPost-treatment Lyme Disease Syndrome
Sana Device for Post-Treatment Lyme Disease Syndrome Chronic Pain
NCT06655844n=20
Oct 2026
Est. completion
NAPostoperative Swelling After TKA
Postoperative Cryocuff vs. Conventional Icepack in TKA - What is More Effective in Reducing Pain and Swelling?
NCT07627854n=102
Apr 2027
Est. completion
NARegional Anesthesia
Ultrasound-Guided Erector Spinae Plane Block Versus Thoracoscopically-Guided Intercostal Nerve Block in Video-Assisted Thoracoscopic Surgery
NCT07535697n=72
Jun 2027
Est. completion
Acute Ischemic Stroke
German Stroke Registry - Endovascular Treatment
NCT03356392n=10,000
Dec 2027
Est. completion
P1Lupus Erythematosus
Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)
NCT06294236n=7
Dec 2030
Est. completion
Leukodystrophy
The Myelin Disorders Biorepository Project
NCT03047369n=12,000
Dec 2035
Est. completion
Lymphedema
An Integrated Algorithm for Surgical Intervention in Chronic Lymphedema After Breast Cancer Treatment: The Basel Lymphedema Protocol
NCT06374745n=500

Awaiting Results (2)

Trials past primary completion date but still active — data readout may be imminent.

Dec 2025
P1
Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID)
NCT06285422
Nov 2025
P1
Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)
NCT05878184

Recent Press Releases